Several clinicians working with investigational peptides report that AOD 9604 appears most effective when the patient is already in a mild caloric deficit and performing regular exercise, as the free fatty acids liberated by the lipolytic process need to be oxidized, not re-stored
This is believed to result from the increased blood volume induced by methylcobalamin
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
Patients should be cautious with any product marketed online for fat loss, anti-aging, metabolism, or longevity without medical oversight
1 week (once daily): 14 swabs 2 weeks (once daily): 28 swabs 4 weeks (once daily): 56 swabs recommend 1 100-count box Protocol Overview Concise summary of the subcutaneous regimen